KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 18 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,329 | -6.8% | 21,494 | 0.0% | 1.07% | -17.3% |
| Q2 2023 | $14,296 | -1.6% | 21,494 | +14.7% | 1.29% | +5.9% |
| Q1 2023 | $14,531 | +45.9% | 18,744 | +42.8% | 1.22% | +67.4% |
| Q4 2022 | $9,961 | -99.9% | 13,126 | 0.0% | 0.73% | +1.2% |
| Q3 2022 | $10,700,000 | +110.7% | 13,126 | +87.5% | 0.72% | +98.3% |
| Q2 2022 | $5,079,000 | -63.5% | 7,000 | -58.1% | 0.36% | -59.9% |
| Q1 2022 | $13,919,000 | +5.2% | 16,700 | 0.0% | 0.90% | -12.3% |
| Q4 2021 | $13,227,000 | +38.4% | 16,700 | +31.5% | 1.03% | +5.7% |
| Q3 2021 | $9,558,000 | -26.7% | 12,700 | -2.3% | 0.98% | -19.2% |
| Q2 2021 | $13,039,000 | +19.8% | 13,000 | +23.8% | 1.21% | +13.2% |
| Q1 2021 | $10,883,000 | – | 10,500 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,000,000 | $6,561,000 | 2.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $22,600,000 | 0.52% |
| Context Capital Management, LLC | 7,000 | $5,079,000 | 0.36% |
| DeepCurrents Investment Group LLC | 11,890,000 | $8,569,000 | 0.34% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $18,139,000 | 0.31% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,500,000 | $4,046,000 | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $12,872,000 | 0.02% |
| BLB&B Advisors, LLC | 100,000 | $73,000 | 0.01% |
| MACKAY SHIELDS LLC | 221,000 | $163,000 | 0.00% |
| JPMORGAN CHASE & CO | 900,000 | $655,000 | 0.00% |